Veru Inc. (LSX:A41ES4) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock (or pre-funded warrants) with accompanying Series A and Series B warrants Closed: US$23.4M raised · US$3 a share · Canaccord Genuity LLC +1 Dealers: Canaccord Genuity LLC (co-lead), Oppenheimer & Co. Inc. (co-lead) Use of proceeds: To start the Phase 2b PLATEAU clinical trial of enobosarm | Dec 17, 2025 |